FRANKLIN LAKES, N.J. (August 20, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a Best Place to Work for Disability Inclusion for the sixth consecutive year following its top score on the Disability Equality Index (DEI).
The DEI is the world's most comprehensive benchmarking tool measuring disability workplace inclusion, and BD has earned the highest possible score (100) for the third straight year. The 2024 DEI evaluated organizations on areas including culture and leadership, enterprise-wide access, employment practices, community engagement and supplier diversity. Organizations scoring 80 or higher are recognized as a “Best Place to Work for Disability Inclusion.”
“This recognition reflects our steadfast commitment to ID&E, which is a lived and prominent part of our culture,” said Nicole Thompson, vice president of Inclusion, Diversity, Equity and Engagement for BD. “We remain focused on making BD a great place to work for all associates, and are honored to be recognized by Disability:IN for our ongoing dedication and progress.”
Limitless, one of nine company-sponsored Associate Resource Groups at BD, serves as a catalyst of support for employees with disabilities through their commitment to advocacy, acceptance and community engagement, so that everyone has an opportunity to contribute. Their collective efforts advance disability inclusion to meet the diverse needs of our associates, customers and communities we serve.
This accolade demonstrates progress against our 2030+ corporate sustainability goals and commitments to maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being, and contributes to advancing equitable health around the world. To learn more, read our 2023 Corporate Sustainability Report and visit BD.com to understand how inclusion, diversity and equity are integral parts of our culture.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts:
Media:
Troy Kirkpatrick
VP, Public Relations
858.617.2361
troy.kirkpatrick@bd.com
Investors:
Adam Reiffe
Sr. Director, Investor Relations
201.847.6927
adam.reiffe@bd.com